Background: Both natural immunity and vaccine-induced immunity to COVID-19 may be
useful to reduce the mortality/morbidity of this disease, but still a lot of controversy exists …

Abstract COVID‐19 convalescent plasma (CCP) was among the few frontline therapies used
to treat COVID‐19. After large randomized controlled trials (RCTs) relying on late use in …

While many studies have documented the intentions for the COVID-19 vaccine booster, few
have explored the change from intention to final decision. This study explores the COVID-19 …

Abstract Emerging Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-Cov-2)
variants continue to be a threat to tackling the pandemic and a challenge to scientists as …

In the years since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic began and spread across the globe, lessons have been learned about the …

Background Previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection primes the immune system; thus individuals who have recovered from infection …

Although vaccines against COVID-19 are effective tools in preventing severe disease, recent
studies have shown enhanced protection after vaccine boosters. The aim of our study was to …

The emergence of SARS-CoV-2 Omicron subvariants prompted countries to call for
accelerated booster vaccinations to limit disease and transmission. Here, we characterized …

Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
humans have been exposed to distinct SARS-CoV-2 antigens, either by infection with …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly
throughout the world, causing severe morbidity and mortality. Since the first reports of …